Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS-Reference-Cited by-同舟云学术

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

Published:2013-02-19 Issue:5-6 Volume:14 Page:397-405
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Beghi Ettore,Pupillo Elisabetta,Bonito Virginio,Buzzi Paolo,Caponnetto Claudia,Chiò Adriano,Corbo Massimo,Giannini Fabio,Inghilleri Maurizio,Bella Vincenzo La,Logroscino Giancarlo,Lorusso Lorenzo,Lunetta Christian,Mazzini Letizia,Messina Paolo,Mora Gabriele,Perini Michele,Quadrelli Maria Lidia,Silani Vincenzo,Simone Isabella L.,Tremolizzo Lucio,

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology

Link

http://www.tandfonline.com/doi/pdf/10.3109/21678421.2013.764568

Reference33 articles.

1. The Heterogeneity of Amyotrophic Lateral Sclerosis: A Possible Explanation of Treatment Failure

2. Role of carnitine esters in brain neuropathology

3. Acetyl-l-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large‐Scale Prospective Study;Annals of Neurology;2024-06-27

2. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies;European Journal of Medicinal Chemistry;2024-06

3. Efficacy of non-pharmacological interventions for individuals with amyotrophic lateral sclerosis: systematic review and network meta-analysis of randomized control trials;Scientific Reports;2024-05-18

4. Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: Current Evidence and Potential use;CNS & Neurological Disorders - Drug Targets;2024-05

5. Glucose hypometabolism prompts RAN translation and exacerbates C9orf72-related ALS/FTD phenotypes;EMBO Reports;2024-04-29